Literature DB >> 33123856

Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma.

Akifumi Nakamura1, Nobuyuki Kondo2, Toru Nakamichi2, Masaki Hashimoto2, Teruhisa Takuwa3, Seiji Matsumoto2, Kozo Kuribayashi4, Takashi Kijima4, Seiki Hasegawa2.   

Abstract

BACKGROUND: A few studies have reported the incidence and clinical implications of complications after pleurectomy/decortication (P/D).
OBJECTIVE: The aim of this study was to assess the details of complications and predictive factors of particularly durable air leak with P/D.
METHODS: Data on 163 consecutive patients who underwent neoadjuvant chemotherapy (NAC) followed by P/D for malignant pleural mesothelioma between September 2012 and May 2020 at our institution were retrospectively analyzed. Postoperative complications and the significance of various preoperative risk factors for air leak > 10 days (AL10) to identify the group having a higher risk for particularly durable air leak were investigated. Risk factors for AL10 were sought using univariate and multivariate analyses.
RESULTS: Of 163 patients, 30- and 90-day mortality was 0.6% and 2.5%, respectively. Eighty-four (51.4%) patients experienced grade III or worse postoperative complications according to the Clavien-Dindo classification. The median duration of air leak was 7 postoperative days. AL10 occurred in 53 (32.5%) patients. Fifty-eight patients (35.6%) underwent pleurodesis and five patients (3.1%) underwent reoperation to control the air leak. On univariate analysis, performance status (PS; p = 0.003), prognostic nutritional index (p = 0.01), and pleural effusion (p = 0.04) were statistically significant risk factors for AL10, while on multivariate analysis, PS (odds ratio 4.0, 95% confidence interval 1.3-12.7; p = 0.02) remained the only variable predicted for AL10.
CONCLUSIONS: Recent postoperative mortality rates in NAC followed by P/D are quite acceptable. Approximately one in every three patients experienced AL10, and PS may be a risk factor associated with AL10.

Entities:  

Mesh:

Year:  2020        PMID: 33123856     DOI: 10.1245/s10434-020-09275-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

Review 1.  New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.

Authors:  Anne S Tsao; Harvey I Pass; Andreas Rimner; Aaron S Mansfield
Journal:  J Clin Oncol       Date:  2022-01-05       Impact factor: 44.544

Review 2.  Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review.

Authors:  Li Yan; Tomoki Nakamura; Andrea Casadei-Gardini; Gema Bruixola; Yuan-Lan Huang; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2021-11

3.  Surgical Diagnosis of Malignant Pleural Mesothelioma: 20 Years' Experience at a High-Volume Referral Center.

Authors:  Amedeo Iaffaldano; Thomas Charrier; Filippo Lococo; Diane Damotte; Antonio Bobbio; Marco Alifano; Ludovic Fournel
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.